Tag: Europe
-
Faster Process Devised for Targeted Antibodies
Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies.
-
Clinical Trial Begins for Liver Dialysis Device
A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
America’s Overdose Epidemic In Perspective
This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries.
-
Students Design Prototype Soft Artificial Heart
Two graduate students in materials science and engineering designed and tested an artificial heart made with soft plastics for eventual use as an implanted device.
-
Broad Institute in Crispr Licensing Program
One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology.
-
Device Shown to Reduce Migraine Occurrence
A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence.
-
Little Health Impact Found from Engineered Mosquitoes
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans.
-
Game App Improves Memory Among Cognitive Impaired
A brain training game for an iPad was shown in a clinical study to improve the memory of people with mild cognitive impairment, a precursor stage to dementia.
-
Glaxo Using Artificial Intelligence for Drug Discovery
Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets.